Skip to content
Overall survival with nephrectomy - results from the CARMENA trial
1.
The CARMENA trial presented recently at ASCO found that for kidney cancer patients diagnosed with metastatic disease, there is no overall survival benefit of having a nephrectomy prior to starting systemic therapy. Knowing that information, would you still want to have a nephrectomy at diagnosis if you were metastatic? Please answer below. We’ll be sharing this information with doctors.
Yes
No
2.
Have you had a nephrectomy for your Kidney Cancer
Yes
No
3.
Were you stage 4 prior to nephrectomy?
Yes
No
4.
Are you on systemic therapy for kidney cancer?
Yes
No
5.
What is your gender?
Male
Female
6.
How old are you (years)?
Current Progress,
0 of 12 answered
